VRTX Stock Recent News

What does it take to qualify as a growth stock? Probably the most important criterion is that the stock must be expected to grow significantly faster than the overall market.

It's been an excellent summer for the broader stock market, with the major indexes hovering around all-time highs and strong earnings from many top companies.

When dark clouds appear on the horizon, it's wise to grab an umbrella, even if the sun is still shining overhead. You'll want to be prepared in case a heavy rain is on the way.

Vertex Pharmaceuticals (VRTX -20.61%) reported its second-quarter results after the market closed on Monday. Its shares plunged more than 17% in early trading on Tuesday.

Vertex Pharmaceuticals Inc VRTX reported better-than-expected earnings for the second quarter after the market close on Monday.

Vertex beats second-quarter earnings and revenue estimates, but shares slide as pain drug VX-993 misses study goal.

Shares of Vertex Pharmaceuticals (VRTX) sank 15% Tuesday, a day after the drugmaker announced a study showed its experimental pain medicine was not successful, and it would no longer move forward with its development.

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Charles F. Wagner - Executive VP, COO & CFO Duncan McKechnie - Corporate Participant Reshma Kewalramani - CEO, President & Director Susie Lisa - Senior Vice President of Investor Relations Conference Call Participants David Reed Risinger - Leerink Partners LLC, Research Division Divya Rao - TD Cowen, Research Division Eliana Rachel Merle - UBS Investment Bank, Research Division Evan David Seigerman - BMO Capital Markets Equity Research Geoffrey Christopher Meacham - Citigroup Inc., Research Division Jessica Macomber Fye - JPMorgan Chase & Co, Research Division Mohit Bansal - Wells Fargo Securities, LLC, Research Division Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division Tazeen Ahmad - BofA Securities, Research Division Terence C.

While the top- and bottom-line numbers for Vertex (VRTX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.